FORMA THERAPEUTICS HOLDINGS (FMTX) Stock Income Statement
USA - NASDAQ:FMTX - US34633R1041 - Common Stock
20.01 USD
+0.03 (+0.15%)
20.01 USD
0 (0%)
| TTM (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 100.60M | 164.10M | |||
| Operating Expenses | 191.13M | 173.99M | 124.10M | 135.70M | 154.40M | |||
| Research and Development | 138.06M | 125.66M | 93.40M | 111.30M | 132.90M | |||
| Selling, General, and Administrative Expenses | 53.06M | 48.33M | 30.80M | 24.40M | 21.50M | |||
| Operating Income | -191.13M | -173.99M | -124.10M | -35.20M | 9.70M | |||
| Interest Income/Expense | 1.39M | 1.05M | 3.40M | 2.90M | 3.70M | |||
| Other Income/Expense | -390.00K | 122.00K | -2.70M | 1.00M | 500.00K | |||
| Non Recurring Items | N/A | 0.00 | 23.20M | -5.30M | 0.00 | |||
| Income Before Taxes | -190.13M | -172.81M | -100.10M | -36.60M | 13.90M | |||
| Income Tax | 28.00K | 154.00K | -29.70M | -1.80M | 8.60M | |||
| Net Income | -190.16M | -172.96M | -70.40M | -34.80M | 5.30M | |||
| EBITDA | -188.56M | -172.42M | -122.82M | -32.53M | 13.23M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.00 | -3.65 | -3.05 | -0.95 | 0.14 | |||
| Non GAAP EPS | -4.00 | -3.65 | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | -34.59% | 3.23% | |||
| Operating Profit Margin | N/A | N/A | N/A | -34.99% | 5.91% | |||
All data in USD